NCT02774434View on ClinicalTrials.gov

Efficacy Study of the Draeger Jaundice Meter (JM-105) in Neonates of ≥ 24 Weeks of Gestational Age

NACompletedINTERVENTIONAL
Enrollment

464

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
HyperbilirubinemiaNeonatal Jaundice
Interventions
DEVICE

JM-105

Measurement of TcB via the JM-105 device

Trial Locations (3)

M5B1W8

Saint Michael's Hospital, Toronto

M5G 1X5

Mount Sinai Hospital, Toronto

Unknown

Hamilton Health Science Centre, Toronto

Sponsors
All Listed Sponsors
lead

Draeger Medical Systems, Inc.

INDUSTRY

NCT02774434 - Efficacy Study of the Draeger Jaundice Meter (JM-105) in Neonates of ≥ 24 Weeks of Gestational Age | Biotech Hunter | Biotech Hunter